Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.

Lee EK, Esselen KM, Kolin DL, Lee LJ, Matulonis UA, Konstantinopoulos PA

Open source

DOI
10.1200/po.20.00063
Published
2020
Container
JCO precision oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/po.20.00063,
  title = {Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.},
  author = {Lee EK and Esselen KM and Kolin DL and Lee LJ and Matulonis UA and Konstantinopoulos PA},
  year = {2020},
  journal = {JCO precision oncology},
  doi = {10.1200/po.20.00063},
  url = {https://doi.org/10.1200/po.20.00063}
}

RIS

TY  - JOUR
TI  - Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.
AU  - Lee EK
AU  - Esselen KM
AU  - Kolin DL
AU  - Lee LJ
AU  - Matulonis UA
AU  - Konstantinopoulos PA
PY  - 2020
JO  - JCO precision oncology
DO  - 10.1200/po.20.00063
UR  - https://doi.org/10.1200/po.20.00063
ER  - 

APA

EK, L., KM, E., DL, K., LJ, L., UA, M., & PA, K. (2020). Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.. JCO precision oncology. https://doi.org/10.1200/po.20.00063

Source records